NCT07585409

Brief Summary

This project aims to identify why some people with Parkinson's disease (PwPD) become less physically active, and which factors support or hinder activity. Understanding these factors is essential for developing person centred interventions and effective support that can be implemented in routine healthcare. A national, multicentre longitudinal cohort study will be conducted including approx 450 PwPD from five Swedish regions (including the internal pilot NCT06901869). Physical activity will be measured objectively with activity monitors, combined with clinical assessments and digital questionnaires over four years. The primary outcome is physical activity level (accelerometer measured decline), and exposure variables include physical, cognitive, disease specific, social, environmental, motivational, and personal factors. Data collection involves clinical tests, questionnaires, accelerometer data, and patient reported experiences. This is a continuation of an internal pilot study NCT06901869. The study will enable early identification of those at risk for declining activity and guide development of person centred, evidence based interventions. Long term, it aims to integrate activity monitoring and risk factor screening into routine care to improve health and quality of life for PwPD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for all trials

Timeline
57mo left

Started Jan 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jan 2026Jan 2031

Study Start

First participant enrolled

January 15, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 7, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 13, 2026

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2031

Last Updated

May 15, 2026

Status Verified

May 1, 2026

Enrollment Period

5 years

First QC Date

May 7, 2026

Last Update Submit

May 13, 2026

Conditions

Keywords

Parkinson's diseasePhysical activityactivity monitorsaccelerometers

Outcome Measures

Primary Outcomes (1)

  • Physical activity - low and moderate intensity

    The primary outcome is changes over time in PA (i.e. low + moderate-vigorous intensity PA in time spent per day) measured with accelerometers (Actigraph GT3X+, Pensacola, FL, US) during 7 days in people with Parkinson's disease everyday life.

    Baseline and yearly follow-ups for 3 years

Secondary Outcomes (5)

  • Physical activity - total vector magnitude

    Baseline and yearly follow-ups for 3 years

  • Physical activity - low intensity

    Baseline and yearly follow-ups for 3 years

  • Physical activity - moderate high intensity

    Baseline and yearly follow-ups for 3 years

  • Physical activity- sedentary

    Baseline and yearly follow-ups for 3 years

  • Physical activity - steps

    Baseline and yearly follow-ups for 3 years

Other Outcomes (21)

  • Disease severity, Parkinsons symptoms

    Baseline and 3 year follow-up

  • Gait

    Baseline and 3 year follow-up

  • Balance performance

    Baseline and 3 year follow-up

  • +18 more other outcomes

Study Arms (1)

People with Parkinson´'s disease

No intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People with Parkinson's disease with mild to severe severity (Hoehn \& Yahr 1-4) of all ages

You may qualify if:

  • People diagnosed with idiopathic Parkinson's disease
  • Hoehn \& Yahr 1 to 4

You may not qualify if:

  • Hoehn \& Yahr 5 (i.e. wheelchair bound or bedridden unless aided)
  • Unable to perform critical physical activity and clinical assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, Sweden

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseMotor ActivitySedentary Behavior

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesBehavior

Study Officials

  • Erika Franzén

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Compliance Office Karolinska Insitutet

CONTACT

Erika Franzén

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 7, 2026

First Posted

May 13, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

January 30, 2031

Last Updated

May 15, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

The datasets generated during and/or analysed during the current study are not publicly available due to Swedish and EU personal data legislation but are available from the principal investigator on reasonable request. Any sharing of data will be regulated via a data transfer and user agreement with the recipient, provided that the recipient has an approved ethics application.

Shared Documents
SAP
Time Frame
We plan to share this when applicable on OSF or similar
Access Criteria
The datasets generated during and/or analysed during the current study are not publicly available due to Swedish and EU personal data legislation but are available from the principal investigator on reasonable request. Any sharing of data will be regulated via a data transfer and user agreement with the recipient.

Locations